{"id":2084,"date":"2026-04-10T08:27:30","date_gmt":"2026-04-10T05:27:30","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/ace-angiotensin-converting-enzim-bos-2\/"},"modified":"2026-09-01T23:55:47","modified_gmt":"2026-09-01T20:55:47","slug":"ace-angiotensin-converting-enzim-bos","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/ace-angiotensin-converting-enzim-bos\/","title":{"rendered":"ACE (Angiotensin Converting Enzim), BOS"},"content":{"rendered":"<h1>ACE (Angiotensin Converting Enzim), BOS<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO2730<\/li>\n<li><strong>SUT Kodu:<\/strong> L100880<\/li>\n<li><strong>Eski Kod:<\/strong> B\u01300005<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<\/ul>\n<h2>ACE (Angiotensin Converting Enzim), BOS Testi Nedir?<\/h2>\n<p>ACE (Angiotensin Converting Enzim), BOS, laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir.<\/p>\n<p>ACE (Anjiotensin Konverting Enzim; Anjiotensin D\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc Enzim), renin-anjiotensin-aldosteron sisteminde (RAAS) anjiotensin I&#8217;i aktif formu olan anjiotensin II&#8217;ye d\u00f6n\u00fc\u015ft\u00fcren ve bradikinini inaktive eden bir enzimdir. Akci\u011fer endotelinde yo\u011fun olarak bulunur. Sarkoidoz ba\u015fta olmak \u00fczere gran\u00fclomat\u00f6z hastal\u0131klarda gran\u00fclom h\u00fccrelerinden (epiteloid h\u00fccreler) salg\u0131lanarak serum d\u00fczeyi y\u00fckselir.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>ACE (Angiotensin Converting Enzim), BOS Hangi Durumlarda \u0130stenir?<\/h2>\n<p>ACE (Angiotensin Converting Enzim), BOS testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Sarkoidoz tan\u0131s\u0131 ve hastal\u0131k aktivitesinin takibi<\/li>\n<li>Gran\u00fclomat\u00f6z hastal\u0131klar\u0131n ay\u0131r\u0131c\u0131 tan\u0131s\u0131<\/li>\n<li>Sarkoidoz tedavi yan\u0131t\u0131n\u0131n izlenmesi<\/li>\n<li>A\u00e7\u0131klanamayan lenfadenopati, \u00fcveit, eritema nodozum, hiperkalsemi de\u011ferlendirmesi<\/li>\n<li>Akci\u011fer infiltrasyonlar\u0131n\u0131n ay\u0131r\u0131c\u0131 tan\u0131s\u0131<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>ACE (Angiotensin Converting Enzim), BOS Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>A\u00e7l\u0131k genellikle gerekmez.<\/li>\n<li>ACE inhibit\u00f6r\u00fc (enalapril, ramipril, lisinopril vb.) kullan\u0131m\u0131 serum ACE d\u00fczeyini d\u00fc\u015f\u00fcr\u00fcr; hekim bilgilendirilmelidir.<\/li>\n<li>ARB (anjiotensin resept\u00f6r blokerleri) ila\u00e7lar ACE d\u00fczeyini etkilemez.<\/li>\n<li>18 ya\u015f\u0131ndan k\u00fc\u00e7\u00fcklerde referans de\u011ferler farkl\u0131d\u0131r (fizyolojik olarak y\u00fcksektir).<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>ACE (Angiotensin Converting Enzim), BOS Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>ACE (Angiotensin Converting Enzim), BOS testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<\/ul>\n<ul>\n<li><strong>Numune tipi:<\/strong> Ven\u00f6z kan (serum)<\/li>\n<li><strong>Numune al\u0131m\u0131:<\/strong> Koldan ven\u00f6z kan al\u0131n\u0131r.<\/li>\n<li><strong>Y\u00f6ntem:<\/strong> Enzimatik (FAPGG substrat\u0131) veya spektrofotometrik y\u00f6ntem<\/li>\n<li><strong>Sonu\u00e7 s\u00fcresi:<\/strong> 1\u20133 g\u00fcn i\u00e7inde sonu\u00e7lan\u0131r.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Grup<\/th><th>De\u011fer Aral\u0131\u011f\u0131<\/th><\/tr><\/thead><tbody><tr><td>Yeti\u015fkin (>18 ya\u015f)<\/td><td>8\u201352 U\/L<\/td><\/tr><tr><td>\u00c7ocuk ve ad\u00f6lesan<\/td><td>Yeti\u015fkin de\u011ferlerinin 1,5\u20132 kat\u0131 olabilir<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>> Not: Referans de\u011ferleri y\u00f6nteme ve laboratuvara g\u00f6re farkl\u0131l\u0131k g\u00f6sterebilir. ACE inhibit\u00f6r\u00fc kullanan hastalarda d\u00fczey bask\u0131lan\u0131r.<\/p>\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>ACE (Angiotensin Converting Enzim), BOS Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<h3>Y\u00fcksek ACE<\/h3>\n<p><strong>Sarkoidoz:<\/strong><\/p>\n<ul>\n<li>Aktif sarkoidozda hastalar\u0131n %40\u201390&#8217;\u0131nda y\u00fcksek bulunur<\/li>\n<li>Hastal\u0131k aktivitesi ile paralel seyreder<\/li>\n<li>Tedavi ile d\u00fc\u015fer; relaps ile tekrar y\u00fckselir<\/li>\n<li>Evre I\u2013II sarkoidozda daha s\u0131k y\u00fcksekken, evre IV&#8217;te (fibrotik) d\u00fc\u015f\u00fck olabilir<\/li>\n<\/ul>\n<p><strong>Di\u011fer gran\u00fclomat\u00f6z hastal\u0131klar:<\/strong><\/p>\n<ul>\n<li>T\u00fcberk\u00fcloz<\/li>\n<li>Lepra<\/li>\n<li>Histoplazmoz<\/li>\n<li>Berilioz<\/li>\n<li>Silikoz<\/li>\n<\/ul>\n<p><strong>Di\u011fer nedenler:<\/strong><\/p>\n<ul>\n<li>Gaucher hastal\u0131\u011f\u0131<\/li>\n<li>Hipertiroidizm<\/li>\n<li>Diabetes mellitus<\/li>\n<li>Karaci\u011fer hastal\u0131klar\u0131 (primer biliyer kolanjit, alkolik hepatit)<\/li>\n<li>Lenfoma<\/li>\n<li>\u0130diyopatik pulmoner fibrozis<\/li>\n<li>Amiloidoz<\/li>\n<\/ul>\n<h3>Normal veya D\u00fc\u015f\u00fck ACE<\/h3>\n<ul>\n<li>ACE inhibit\u00f6r\u00fc kullan\u0131m\u0131 (ila\u00e7 etkisi)<\/li>\n<li>\u0130naktif veya tedavi alt\u0131ndaki sarkoidoz<\/li>\n<li>Hipotiroidizm<\/li>\n<li>KOAH (baz\u0131 vakalarda)<\/li>\n<li>Sarkoidoz d\u0131\u015f\u0131 nedenli akci\u011fer hastal\u0131klar\u0131 (\u00e7o\u011funda normal)<\/li>\n<\/ul>\n<h3>Sarkoidozda Klinik Kullan\u0131m<\/h3>\n<ul>\n<li>ACE tek ba\u015f\u0131na sarkoidoz tan\u0131s\u0131 koymak i\u00e7in yeterli de\u011fildir (duyarl\u0131l\u0131k %40\u201390, \u00f6zg\u00fcll\u00fck %80\u201390).<\/li>\n<li>Tan\u0131 biyopsi ile do\u011frulanmal\u0131d\u0131r.<\/li>\n<li>ACE d\u00fczeyi hastal\u0131k aktivitesinin takibinde ve tedavi yan\u0131t\u0131n\u0131n izlenmesinde faydal\u0131d\u0131r.<\/li>\n<li>Normal ACE d\u00fczeyi sarkoidozu ekarte ettirmez.<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>ACE inhibit\u00f6r\u00fc kullanan hastalarda serum ACE d\u00fczeyi d\u00fc\u015f\u00fck olaca\u011f\u0131ndan test anlaml\u0131 de\u011fildir; bu ila\u00e7lar\u0131n kullan\u0131l\u0131p kullan\u0131lmad\u0131\u011f\u0131 mutlaka sorgulanmal\u0131d\u0131r.<\/li>\n<li>\u00c7ocuklarda ve adolesanlarda ACE d\u00fczeyi fizyolojik olarak y\u00fcksektir; yeti\u015fkin referans de\u011ferleri kullan\u0131lmamal\u0131d\u0131r.<\/li>\n<li>ACE d\u00fczeyi sarkoidoz i\u00e7in ne tam duyarl\u0131 ne de tam \u00f6zg\u00fcd\u00fcr; klinik, radyolojik ve histopatolojik verilerle birlikte de\u011ferlendirilmelidir.<\/li>\n<li>Genetik polimorfizm (ACE gen insersion\/deletion polimorfizmi) bazal ACE d\u00fczeyini etkiler.<\/li>\n<li>Seri \u00f6l\u00e7\u00fcmlerle takip, tek \u00f6l\u00e7\u00fcmden daha de\u011ferlidir.<\/li>\n<li>Hemolizli ve lipemik numuneler sonu\u00e7lar\u0131 etkileyebilir.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>ACE (Angiotensin Converting Enzim), BOS Laboratuvar Bilgileri Yeni Kod: BIO2730 SUT Kodu: L100880 Eski Kod: B\u01300005 Kategori: Biyokimya \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. ACE (Angiotensin Converting Enzim), BOS Testi Nedir? ACE (Angiotensin Converting Enzim), BOS, laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. ACE (Anjiotensin Konverting Enzim; Anjiotensin [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO2730","numune_turu":"","numune_kabi":"","calisma_gunu":"","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"L100880","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-2084","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=2084"}],"version-history":[{"count":4,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2084\/revisions"}],"predecessor-version":[{"id":8872,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2084\/revisions\/8872"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=2084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}